Pfizer and Moderna have formally asked U.S. regulators to grant emergency authorization for new COVID-19 vaccine boosters for children as young as five. Pfizer and its partner BioNTech submitted a request to the U.S. Food and Drug Administration (FDA) on Sept. 26, several days after Moderna submitted a request to the FDA. The FDA authorized…
Pfizer, Moderna Ask US Regulators for Emergency Authorization for New Boosters for Children
Top Pro-Vaccine Doctor Calls for Global Pause of Messenger RNA COVID-19 Vaccines
September 26, 2022
admin
Aseem MalhotraCCP VirusCOVID-19 VaccinesEditor's PicksInternationalModernaPfizerVaccines & SafetyWorld
0 Comment
A doctor who promoted COVID-19 vaccines in 2020 and 2021 is now calling for health authorities around the world to pause administration of two of the most-widely utilized COVID-19 vaccines, asserting that the benefits from the vaccines may not outweigh the risks. “There is more than enough evidence—I would say the evidence is overwhelming—to pause…
Israeli Investigators Find COVID-19 Vaccines Cause Side Effects: Leaked Video
September 23, 2022
admin
BrightCCP VirusCOVID-19 vaccineEditor's PickshealthHealth NewsIsraeliMiddle EastPfizerPublic HealthSocietyVaccines & SafetyWorld
0 Comment
Israeli researchers found some side effects that occurred after COVID-19 vaccination were caused by Pfizer’s vaccine, according to a leaked video. The Israeli Ministry of Health (MoH) commissioned researchers to analyze adverse event reports submitted by Israelis and the researchers presented findings from the new surveillance system in an internal June 2022 meeting, video of…
COVID-19 Vaccine Effectiveness Estimated to Turn Negative Over Time in Children: Study
The effectiveness of Pfizer’s COVID-19 vaccine against infection turned negative over time for children aged 5 to 11, according to a new study. Researchers found that for kids in the age group, the effectiveness peaked at 60 percent to 70 percent several weeks after the first dose. It then dropped, nearing zero at week 18…
AstraZeneca Beats US Shareholder Lawsuit Over COVID-19 Vaccine Disclosures
NEW YORK—AstraZeneca Plc. on Monday won the dismissal of a U.S. shareholder lawsuit claiming that it concealed problems in developing its COVID-19 vaccine, making it unlikely the treatment would win regulatory approval in the United States. U.S. District Judge Paul Oetken in Manhattan said AstraZeneca shareholders in the proposed class action failed to identify any…
Pfizer to Acquire Australian Digital Health Company for $180 Million
September 7, 2022
admin
AustraliaBusiness & MarketsCompaniesHealth & SafetyLifestylePfizerScienceScience NewsTechTech NewsWorld
0 Comment
The majority of shareholders of a small digital health company in Brisbane have approved the $180 million (US$121 million) takeover bid from global pharmaceutical giant Pfizer. During a virtual scheme meeting on Sept. 7, nearly 83 percent of ResApp’s shares were voted in favour of the takeover, which exceeded the 75 percent supermajority required. While…
Pfizer, BioNTech Seek to Revoke CureVac’s Patent Infringement Claims
Pfizer and its German partner BioNTech have filed proceedings at the High Court of England and Wales, seeking a judgment that their COVID-19 vaccine, based on mRNA technology, does not infringe on CureVac’s European patents, according to a regulatory filing on Friday. In July, CureVac had filed a patent lawsuit against BioNTech over its use…
Pfizer Has Stopped Its COVID Vaccine Clinical Trial in Pregnant Women: Internal Email
Pfizer and BioNTech’s clinical trial to evaluate their COVID-19 vaccine in pregnant women has been discontinued, according to a newly disclosed internal Pfizer email filed as evidence in a recent court case. The case in part challenges if the vaccine has been adequately tested to assess for risks to women’s reproductive health. A professor of…
FDA Authorizes Updated COVID-19 Boosters Despite Lack of Clinical Data
U.S. drug regulators on Aug. 31 authorized COVID-19 vaccine booster shots despite no clinical trial data being available for the updated formulations. The U.S. Food and Drug Administration (FDA) granted emergency use authorization to Moderna and Pfizer for their updated boosters. The original vaccines were based on components of the Wuhan strain of the virus…
Inflammatory mRNA Nanoparticles Inhibits and Alters Immune Response: Pre-Print Study
August 31, 2022
admin
AMERICABrightCCP VirusCOVID-19 vaccinehealthHealth 1+1Health ConditionsmedicineModernamRNAnanoparticlePfizerUSUS NewsVaccines
0 Comment
A recent preprint study has shed light on why adverse events have been observed following a COVID-19 messenger RNA (mRNA) vaccination. The study, led by researchers from Thomas Jefferson University found that the lipid nanoparticles (LNPs) used to transport mRNA in COVID-19 vaccines could “inhibit” and “alter” immune responses in mice. LNPs are shells of lipids…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta